Haitao Xing

ORCID: 0009-0005-8277-9365
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metabolomics and Mass Spectrometry Studies
  • Traditional Chinese Medicine Studies
  • Sepsis Diagnosis and Treatment
  • Chronic Kidney Disease and Diabetes
  • Genetic Associations and Epidemiology
  • Genetic Syndromes and Imprinting
  • Gout, Hyperuricemia, Uric Acid
  • Dialysis and Renal Disease Management
  • Diet and metabolism studies
  • Potassium and Related Disorders
  • Metabolism and Genetic Disorders
  • Pharmacological Effects of Natural Compounds
  • Advanced Chemical Sensor Technologies
  • Respiratory Support and Mechanisms
  • Computational Drug Discovery Methods
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Ginseng Biological Effects and Applications
  • Heme Oxygenase-1 and Carbon Monoxide
  • Acute Kidney Injury Research
  • Gut microbiota and health
  • Heart Failure Treatment and Management
  • Traditional Chinese Medicine Analysis
  • Oral microbiology and periodontitis research
  • Cancer-related molecular mechanisms research
  • Thermal Regulation in Medicine

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
2024

Tianjin University of Traditional Chinese Medicine
2004-2024

Heilongjiang University of Chinese Medicine
2015-2016

Harbin University
2015-2016

First Affiliated Hospital of Heilongjiang University of Chinese Medicine
2015-2016

Tianjin University
2007

At present, safe and effective treatment drugs are urgently needed for diabetic kidney disease (DKD). Circulating protein biomarkers with causal genetic evidence represent promising drug targets, which provides an opportunity to identify new therapeutic targets. Summary data from two quantitative trait loci studies presented, one involving 4,907 plasma proteins 35,559 individuals the other encompassing 4,657 among 7,213 European Americans. statistics DKD were obtained a large genome-wide...

10.2337/db23-0564 article EN Diabetes 2024-01-11

Early diagnosis of Alzheimer's disease (AD) is an attractive strategy to increase the survival rate patients.

10.1039/c5ra19094k article EN RSC Advances 2015-01-01

Background In recent years, the role of gut microbiota and derived metabolites in renal disease has attracted more attention. It been established that is a potential target for medical interventions including chronic kidney (CKD), acute injury (AKI) calculus. Emerging evidence related dialysis treatment to microbial composition function intestines, there are many reports HD, but few studies have PD. Previous found PD patients intestinal flora disturbances, so we speculate its may be...

10.3389/fmed.2023.1302352 article EN cc-by Frontiers in Medicine 2024-01-05

A nontargeted metabolomics approach was developed to examine metabolic differences in serum samples from the mild cognitive impairment and Alzheimer's disease subjects.

10.1039/c5ra19349d article EN RSC Advances 2016-01-01

Severe sepsis (SS) remains among the leading causes of death in both developed and developing countries.

10.1039/c6ra07514b article EN RSC Advances 2016-01-01

Hyperuricemia (HUA), a condition characterized by elevated levels of uric acid (UA) in the bloodstream, is intricately connected to an imbalance gut microbiota. UA, byproduct purine metabolism, serves as crucial endogenous antioxidant. Recent research indicates that modifying microbiome offers promising avenue for managing HUA. This work delves into complex relationship between HUA and changes microbiota, examining its impact on UA excretion, reabsorption, activity enzymes involved...

10.36922/ejmo.8579 article EN Eurasian Journal of Medicine and Oncology 2025-03-25

Urinary UPLC-MS metabolomics could dissect the underlying mechanisms of HXC protects against SS.

10.1039/c6ra07987c article EN RSC Advances 2016-01-01

Non-targeted mass spectrometry was used to characterize peripheral biomarkers associated with the urine metabolome in severe sepsis (SS) patients. This is an efficient and convenient tool for diagnosing screening of SS a high-risk population.

10.1039/c5ra19875e article EN RSC Advances 2015-01-01

Cholangiocarcinoma (CC) accounts for approximately 25% of all hepatobiliary malignancies, including intra- and extrahepatic cholangiocarcinoma (ICC ECC) has a high mortality rate. The clinical manifestations liver function tests the ICC ECC diseases are too similar to distinguish between them. Diagnosis remains difficult because lack sensitive diagnostic tests, although MRI CT with endoscopic ultrasound provide useful information in certain patients, but invasive, time-consuming or...

10.1039/c5mb00572h article EN Molecular BioSystems 2015-11-13

Sepsis is a commonly encountered scenario in an intensive care unit (ICU), and the kidney one of organs frequently affected.

10.1039/c6ra01192f article EN RSC Advances 2016-01-01

Sepsis-induced acute lung injury (ALI) remains a leading cause of death in intensive care units and early detection is very important. This work showed that metabolite phenotype profiling might be useful tool for the effective diagnosis further understanding ALI.

10.1039/c5ra25961d article EN RSC Advances 2016-01-01

The aim of this study was to use lipidomics identify lipid molecules that could predict patients with sepsis-induced lung injury.

10.1039/c6ra03979k article EN RSC Advances 2016-01-01

<p dir="ltr"><a href="" target="_blank">At present, safe and effective treatment drugs are urgently needed for diabetic kidney disease (DKD). Circulating protein biomarkers with causal genetic evidence represent promising drug targets, which provides an opportunity to identify new therapeutic targets. Summary data from two quantitative trait loci (pQTL) studies: one involving 4,907 plasma proteins 35,559 individuals, the other encompassing 4,657 among 7,213 European Americans....

10.2337/figshare.24964149 preprint EN cc-by-nc-sa 2024-01-11

<p dir="ltr"><a href="" target="_blank">At present, safe and effective treatment drugs are urgently needed for diabetic kidney disease (DKD). Circulating protein biomarkers with causal genetic evidence represent promising drug targets, which provides an opportunity to identify new therapeutic targets. Summary data from two quantitative trait loci (pQTL) studies: one involving 4,907 plasma proteins 35,559 individuals, the other encompassing 4,657 among 7,213 European Americans....

10.2337/figshare.24964149.v1 preprint EN cc-by-nc-sa 2024-01-11

Network pharmacology was employed to probe into the mechanism of Fushen Granules in treating peritoneal dialysis-rela-ted peritonitis(PDRP) rats. The main active components were searched against Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, their targets predicted. PDRP-related retrieved from DisGeNET other databases. common shared by drug disease identified online tool, protein-protein interaction(PPI) network targets. obtained 276 imported DAVID for GO...

10.19540/j.cnki.cjcmm.20231210.503 article EN PubMed 2024-03-01
Coming Soon ...